Aryloxazolidinediones: identification of potent orally active PPAR dual α/γ agonists

Aryloxazolidinediones: identification of potent orally active PPAR dual α/γ agonists 5-Aryl thiazolidine-2,4-diones: discovery of PPAR dual α/γ agonists as antidiabetic agents Pyridine-2-propanoic acids: Discovery of dual PPARα/γ agonists as antidiabetic agents Pyridine-3-propanoic acids: Discovery of dual PPARα/γ agonists as antidiabetic agents Design, synthesis, and evaluation of 2-alkoxydihydrocinnamates as PPAR agonists Discovery of a Novel Series of Peroxisome Proliferator-Activated Receptor α/γ Dual Agonists for the Treatment of Type 2 Diabetes and Dyslipidemia 5-Aryl thiazolidine-2,4-diones as selective PPARγ agonists Design, synthesis and evaluation of novel zwitterionic compounds as PPARα/γ dual agonists (1) (S)-3-(4-(2-(5-Methyl-2-phenyloxazol-4-yl)ethoxy)phenyl)-2-(piperazin-1-yl)propanoic acid compounds: Synthesis and biological evaluation of dual PPARα/γ agonists Design, synthesis, and evaluation of novel aryl-tetrahydropyridine PPARα/γ dual agonists